BTIG analyst Ryan Zimmerman has maintained their neutral stance on SOLV stock, giving a Hold rating today.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Ryan Zimmerman has given his Hold rating due to a combination of factors impacting Solventum Corporation’s performance. The company reported strong third-quarter results with revenue and adjusted earnings per share surpassing expectations, driven by favorable performance in the Dental segment. However, despite these positive results, there are concerns about the company’s ability to sustain this growth due to potential headwinds such as tariff impacts and limited opportunities for operational margin expansion in the upcoming fiscal year.
Additionally, while Solventum has improved its leverage position and is on track to meet its long-term targets, the expected muted earnings growth in the near term and the ongoing costs associated with its transformation initiatives contribute to a cautious outlook. The company’s valuation appears fair when compared to peers with similar growth profiles, which supports the decision to maintain a Hold rating rather than a more aggressive recommendation.
In another report released today, Bank of America Securities also reiterated a Hold rating on the stock with a $85.00 price target.
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SOLV in relation to earlier this year.